The largest database of trusted experimental protocols
> Physiology > Clinical Attribute > Cancer Survivorship

Cancer Survivorship

Cancer survivorship refers to the health and well-being of individuals who have been diagnosed with cancer, from the time of initial diagnosis through the remainder of their lives.
This encompasses physical, psychologycal, and social aspects, as well as the effects of the cancer and its treatment.
Cancer survivorship research aims to optimize care and improve quality of life for those living with and beyond cancer.
Key areas of focus include managing long-term and late effects, promoting wellness and prevention, and addressing disparities in survivorship outcomes.

Most cited protocols related to «Cancer Survivorship»

In 2004, the NCI issued the original TREC Request for Applications (RFA) using a U54 cooperative agreement grant mechanism. Applicants were required to demonstrate a transdisciplinary approach, propose 3-5 individual and connected research projects organized around a unifying research theme. Applications also included several cores (e.g., administration, bioinformatics, developmental pilot projects, education/training) as well as strategies to synthesize efforts across centers and plans to disseminate results to the medical, public health, policy, and cancer research community. The education/training component was included in recognition of the urgent need for new investigators in the area of energetics-cancer research. The provision of developmental/pilot funds supports exploration of novel directions, especially those that might arise with the progression of the major projects.
In 2005, four TREC Centers were selected by a national peer review process. The four Centers (principal investigators) originally funded under this mechanism were: Case Western Reserve University (Nathan A. Berger, MD), Fred Hutchinson Cancer Research Center (Anne McTiernan, MD, PhD), University of Minnesota (Robert W. Jeffery, PhD), and University of Southern California (Michael I. Goran, PhD). The Fred Hutchinson Cancer Research Center was funded to be the Coordination Center. These TREC Centers were highly productive, transdisciplinary in focus and contributed greatly to the understanding of transdisciplinary team science [28 -30 (link)]. TREC research finds have been reported elsewhere and cover a wide scope of results. Select highlights include: findings on the effects of diet quality on inflammatory and adipokine profiles of overweight and obese individuals [31 (link)], to the impact of adipocytes on leukemia treatment [32 (link)], to the effects of exercise on oxidative stress in overweight or obese women [33 (link)], as well as the relationship of sleep duration to increased cancer risk [34 (link)]. TREC research highlights are available at http://trecscience.org/trec/bin/scientist/pubs.aspx?j=21. A comprehensive publication list and further details describing the initial TREC Centers are publicly available on the TREC project website (http://trecscience.org/trec/bin/about/archive05.aspx?j=21).
In 2009, the NCI issued a revised TREC Request for Applications (RFA). The focus of the 2009 RFA was expanded to reflect the current state of the evidence, which had grown dramatically since 2004. The TREC RFA 2009 was released for open competition, and included modifications to strengthen the RFA's transdisciplinary focus between the relationships of obesity, cancer etiology and mechanisms and the cancer survivorship population. This second phase of TREC continued using a U54 cooperative agreement grant mechanism, including a limited competition U01 RFA for the Coordination Center. This manuscript is focused on the results of the 2009 TREC RFA. Below we provide an overview of the 2011-2016 TREC Collaborative Network as well as the 4 Centers and the 15 research projects being conducted at the Centers.
Publication 2013
Adipocytes Adipokines Cancer Survivorship Cordocentesis Diet Disease Progression Infantile Neuroaxonal Dystrophy Inflammation Leukemia Malignant Neoplasms Obesity Oxidative Stress Peer Review Woman
The goal of scale revision was to identify a comprehensive, reproducible, and valid set of scales measuring concerns relevant to long-term cancer survivorship, with each scale composed of a set of internally consistent items. To achieve this end, our strategy was 1) to extract scales that were based on the IOC questionnaire items by use of exploratory factor analysis (39 , 40 ); 2) to perform split-sample cross-validation to assess reproducibility of the scales across subsamples (40 ); and 3) to conduct psychometric evaluation to assess the construct and concurrent validity of the proposed scales (41 ).
Exploratory factor analyses were conducted by use of the FACTOR procedure in SAS version 9.1 software (SAS Institute, Inc., Cary, NC). To decrease the dependence of our findings on any particular factor analytic technique, we used three methods of factor extraction (principal components, maximum likelihood, and unweighted least squares) and two methods for selecting the number of factors [the Kaiser-Guttman criterion of retaining factors with eigenvalues greater than 1 (42 , 43 ) and Cattell scree plot technique (44 )] and retained only those items that had factor loadings of greater than 0.50 by all approaches and loaded on factors with a clear interpretation. After factor extraction, we conducted factor rotation, an algorithmic procedure that achieves simplified factor structure by optimizing the grouping of items with common characteristics onto common factors. Because factors were expected to be correlated, we used the oblique promax rotation procedure (45 ).
The reproducibility of factor structure across subsamples was assessed by use of the targeted rotation method of McCrae et al (46 ). This method tests the hypothesis that the factor structure represented in the first sample is replicated in the second sample by extracting the hypothesized number of factors from the second sample, performing a targeted rotation to align the axes in the second factor structure with the axes in the first factor structure (the target), and calculating coefficients of congruence that quantify the fit between the two factor structures. Congruence coefficients compare two sets of factor loadings (item–factor correlations) in terms of both the pattern and magnitude of the loadings and can range from +1 (perfect agreement) to –1 (perfect inverse agreement). The observed congruences are compared with critical values generated by use of Monte Carlo techniques to determine the statistical significance of the fit. We defined a statistically significant congruence as a congruence higher than 95% of congruences obtained by rotating the second factor structure to align with axes in randomly generated target factor structures. For this analysis, we used the SAS Interactive Matrix Language program provided as an appendix in McCrae et al (46 ).
Psychometric evaluation included computation of Cronbach's coefficient alpha statistic for each scale as a measure of internal consistency reliability (47 ). Scales are generally considered reliable if the alpha statistic exceeds 0.70 (48 ). We also computed the coefficient delta or delta statistic, an index of the ability of a scale to discriminate among individuals (49 (link)). The delta statistic can range from 0, corresponding to all respondents giving the same response, to 1, corresponding to a maximally discriminating scale in which responses are uniformly distributed across the range of possible values (49 (link), 50 (link)).
The validity of the scales was evaluated by use of several strategies. Face validity was evaluated by examining item content. Construct validity, including convergent and discriminant validity, was evaluated by examining the Pearson product-moment correlation coefficients (r) among the scale scores and patterns of relationships between the scale scores and the sociodemographic, medical, and treatment characteristics of the sample cross-sectionally. For the latter, scale scores were examined for differences, or lack thereof, across age, years since diagnosis, partnered status, breast-conserving surgery vs mastectomy, chemotherapy status, general health status, number of comorbidities, body mass index, adjuvant hormonal therapy use, and current antidepressant use for depression or anxiety. These analyses used correlation coefficients for continuous variables and analysis of variance (ANOVA) for categorical variables. Concurrent validity was evaluated by forming a priori hypotheses about patterns of association and correlating the scales scores with the CES-D scores and the BCPT symptom scale total and subscale scores. When evaluating the quantitative significance of correlations, we considered an |r| of less than 0.30 to indicate a negligible association, |r| between 0.30 and 0.45 to indicate a moderate association, |r| between 0.45 and 0.60 to indicate a substantial association, and |r| greater than 0.60 to indicate a strong association (51 (link)). In the validity analyses, we used a P value of less than .005 as the critical value for statistical significance to account for the large sample size and multiple comparisons. All P values and tests of statistical significance were two-sided.
We computed scores for both higher-order scales and subscales as the mean of non-missing items that composed the scale. Scores were considered missing if more than 50% of items were missing.
Publication 2008
Antidepressive Agents Anxiety Breast-Conserving Surgery Cancer Survivorship Diagnosis Epistropheus Index, Body Mass Mastectomy Pharmaceutical Adjuvants Pharmacotherapy Psychometrics Specimen Handling Therapeutics

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017
Cancer Survivors Cancer Survivorship Diagnosis Electricity Foot Love Mitochondrial Diseases Nervous System, Autonomic Pain Pain Disorder Patients Peripheral Vascular Diseases Platinum Pruritus Severity, Pain Survivors Taxanes Thyroid Gland Vitamin B 12 Deficiency Woman
This is a population-based study that will enroll all eligible adult patients served by clinicians in the Division of Medical Oncology at MCR and in hematology-oncology services at MCHS sites. This inclusive enrollment approach substantially increases the generalizability and external validity of our real-world pragmatic trial. Specifically, the E2C2 pragmatic trial will include all adult patients being treated or monitored for cancer or receiving survivorship care for cancer at the MCR medical oncology practice and the MCHS hematology-oncology practices. MCR patients in this trial will have solid tumors, and MCHS patients may have solid or liquid tumors. Data will not be used from patients who have indicated that they do not want their EHR data used for research according to the Minnesota Health Records Act [59 ].
Full text: Click here
Publication 2020
Adult Cancer Survivorship Inclusion Bodies Malignant Neoplasms Methacholine Neoplasms Patients
The Detroit Research on Cancer Survivors (ROCS) cohort study enrolls African Americans diagnosed with lung, breast, prostate or colorectal cancer and their caregivers. These cancers were selected because they contribute greatly to the cancer burden, occur at the highest frequency in African Americans, and represent cancers with a range in survival times and disease severity. This population-based African-American cancer cohort will ultimately include over 5,000 cancer survivors with annual follow-up for up to five years, supporting a broad research agenda aimed at identifying major factors affecting cancer survivorship in African Americans. A detailed description of eligibility criteria for the study includes: 1) self-identification as African American or black; 2) an age at cancer diagnosis of 20–79 years; 3) a date of diagnosis on or after January 1, 2013; 4) a diagnosis of first primary invasive lung, female breast, prostate or colorectal cancer; 5) a resident of Wayne, Oakland or Macomb county, Michigan at time of diagnosis; and 6) alive at study contact. The study protocol, all questionnaires, and study documents were reviewed and approved by the Institutional Review Board at Wayne State University (IRB #050417M1F).
Publication 2020
African American Breast Cancer Survivors Cancer Survivorship Colorectal Carcinoma Diagnosis Eligibility Determination Lung Malignant Neoplasms Prostate Woman

Most recents protocols related to «Cancer Survivorship»

The current analysis is derived from a subset of a 190-item online survey assessing cancer survivorship practices, services, and care delivery at COG institutions [28 ]. In follow-up to a 2007 survey of COG survivorship practices [13 (link)], respondents were asked to report institutional characteristics, including institution type, size, upper age limits for newly diagnosed patients, institutional policies on age at transfer, and models of care for adult survivors of childhood cancer.
If respondents reported their institution transferred patients out for long-term follow-up care in adulthood (e.g., their institution transferred patients at a certain age or transferred survivors "when they are ready"), they were asked to complete nine items related to healthcare transition programming. These items included identifying (1) the top two most difficult barriers to transitioning survivors to adult care providers for cancer-related care, (2) care team members involved in introducing and coordinating transition, (3) when in the cancer trajectory sites typically introduce the concept of transition, and (4) if sites had implemented transition programming (6 items) aligned with the six core elements of Health Care Transition 2.0 from the US Center for Health Care Transition Improvement [14 (link)]. If respondents reported their patients are “seen indefinitely and not transferred elsewhere,” they were not asked any further questions about institutional healthcare transition supports. All respondents were allowed to omit responses to individual questions at their discretion.
Publication 2023
Adult Cancer Survivorship Delivery of Health Care Follow-Up Care Malignant Neoplasms Outpatients Patients Patient Transition Survivors Survivors of Childhood Cancer Vision
The research team consisted of researchers and clinicians with experience and expertise in persistent pain, pain management, cancer survivorship and qualitative study methods. Participants were invited to participate in the study through emailing members of the Breast Cancer Network Australia Review and Survey Group, and via advertisement on social media platforms, newsletters and posters. Eighteen women expressed interest to participate in the study, of whom four were excluded because they did not meet the inclusion criteria (n = 2) or did not have time to participate (n = 2). We were able to interview 14 participants who were all given the choice to participate in either a focus group, or in individual semi-structured interviews. Four participants opted for the focus group and ten participants for the semi-structured interviews.
All interviews were conducted by a female investigator (JM) who had a background in Physiotherapy and creative arts and was trained to conduct the interviews by an experienced qualitative researcher. A second investigator attended the interviews to take field notes about interactions between interviewer and interviewee and the physical environment. The second investigator was either a social worker with expertise in qualitative research and chronic pain (MN) or a physiotherapist trained in qualitative methodology (MS). There were no prior relationships between the interviewers and any of the interviewees and participants were not financially compensated for their participation. The a priori developed semi-structured interview guide was followed. The focus group and interviews were audio-recorded and transcribed verbatim by the researcher who conducted the interviews. Recruitment, data collection and analysis proceeded concurrently until data saturation was reached (i.e., when no new consistent themes were emerging) (22 ). Participants did not comment on transcripts or initial findings.
Full text: Click here
Publication 2023
Cancer Survivorship Chronic Pain Females Interviewers Malignant Neoplasm of Breast Management, Pain Pain Physical Examination Physical Therapist Therapy, Physical Woman Worker, Social
Participants assigned to the attention control group (Figure 2) were provided a Xiaomi Mi Band 3 and took part in a weekly telephone-based BC support group for 12 weeks. Attention control was used to ensure the same dose of interaction with a facilitator as intervention participants [47 (link)]. A Xiaomi Mi Band 3 was provided as a self-monitoring tool. This activity tracker was selected because the associated app did not include as many behavior change techniques as the Fitbit app [48 (link)]. It does provide progressive step goal notifications and a “reach goal” badge when a person reaches the step goal. Similar to the intervention group, a study email and an anonymous Mi Band account were set up for each of the participants to protect their identity. The team also purchased app-based phone numbers for use with the Mi Band app. A master’s degree-level research dietitian (SJW) facilitated the BC support group discussions. The attention control group did not receive the behavioral coaching and exergame components of the Pink Warrior 2 intervention. Instead, they were provided same resources from the National Coalition for Cancer Survivorship and the American Cancer Society as the intervention group to elicit survivorship navigation discussions. Each telephone-based BC support group session also lasted about 1 h. This kind of control intervention was selected because of the well-documented effects of attention in studies promoting behavior change [47 (link)].
Full text: Click here
Publication 2023
Attention Behavior Therapy Cancer Survivorship Dietitian
A standard content analysis approach [46 ] was used to analyze the participants’ narratives. The analytic team included investigators with expertise in cancer survivorship, partnered relationships (A.A.C.), and qualitative methodology (C.B.D.), in addition to a nursing graduate student (J.S.A.). Data analysis occurred in six steps. First, team members constructed a data display table, in which the main topics (e.g., challenges, strategies, suggestions for providers) were used as column headers and each row was labeled with the participant identification numbers. Second, after reading the transcripts in their entirety, a code was assigned to each remark related to the study aims. Third, final codes were placed in the appropriate cells in the data display table (e.g., participant PA-001 X Needing information/knowledge about cancer). Through discussion and consensus, the analytic team grouped similar codes within each column into categories. Then, the categories were organized into five groups (A.A.C. and C.B.D.) representing common psychosocial experiences of the participants. Narrative summaries of challenges, strategies, and recommendations associated with each experience were compiled. Finally, summaries were presented to the investigative team, discussed, and finalized.
Full text: Click here
Publication 2023
Cancer Survivorship Malignant Neoplasms Place Cells Students, Nursing
The primary goal of the flexible, tailored participation in the Beyond Cancer intervention was to facilitate work readiness and the gradual return to sustainable, suitable work for each individual. The extent, timing and type of program participation was jointly determined by the OR consultant and the cancer survivor. Intervention components were delivered, as required, in a tailored fashion to breast cancer survivors from around week 5 after referral. Early sessions were used to establish the level of intervention support and services required, as well as the type of services (intervention components) to best support the individual with moving toward work readiness.
Due to COVID-19 restrictions and associated vulnerabilities of the cancer population, the Beyond Cancer program was delivered in a tailored fashion using a combination of face-to-face, telehealth and telephone OR consultation sessions by an experienced OR consultant trained in cancer survivorship. The intervention had four main components: The delivery and doses were determined following completion of the psychosocial PositivumTM assessment and an initial discussion between the OR consultant and the survivor. Using the Positivum Assessment, the OR consultant identified key barriers and facilitators to work readiness and tailored the intervention accordingly (see Figure 1).
The Positivum biopsychosocial assessment was used to (1) inform the OR consultants on the survivors’ biopsychosocial needs and (2) as a measure of survivors’ response to the intervention. The Positivum biopsychosocial assessment is a 50-item tool with Likert-style response options developed and tested by our team to determine individuals’ strengths and weaknesses across a range of biopsychosocial constructs. The following psychosocial factors are included: quality of life and general health; pain; physical fatigue; cognitive fatigue; beliefs, perceptions and expectations of health; work and employer; distress and fear of recurrence; empowerment/resilience and perceived support at work. Further information about the validated instruments is provided in our protocol [38 (link)]. The assessment provides a high-level individual profile in a standardised report output that is easily interpreted by the trained OR consultant and the cancer survivor, and subsequently used to tailor the intervention services offered during the initial stages of the intervention. The Positivum assessment was delivered online and implemented at referral and again immediately following intervention completion.
Full text: Click here
Publication 2023
Breast Cancer Survivors Cancer Survivorship Cognition Consultant COVID 19 Debility Face Fatigue Fear Malignant Neoplasm of Breast Malignant Neoplasms Obstetric Delivery Pain Physical Examination Recurrence Survivors Telehealth Vulnerable Populations

Top products related to «Cancer Survivorship»

Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, Austria
Stata V.16 is a comprehensive statistical software package developed by StataCorp. It provides a wide range of data management, statistical analysis, and visualization tools for researchers and professionals across various fields. Stata V.16 offers a user-friendly interface and a powerful programming language to facilitate data analysis and reporting.
Sourced in United States, Denmark, Austria, United Kingdom, Japan, Canada
Stata version 14 is a software package for data analysis, statistical modeling, and graphics. It provides a comprehensive set of tools for data management, analysis, and reporting. Stata version 14 includes a wide range of statistical techniques, including linear regression, logistic regression, time series analysis, and more. The software is designed to be user-friendly and offers a variety of data visualization options.
Sourced in United States, Cameroon, Japan
The SAS System for Windows is a comprehensive software suite for data analysis, management, and reporting. It provides a powerful platform for statistical analysis, data mining, and business intelligence. The SAS System for Windows includes a wide range of tools and functionalities to help users effectively manage and analyze their data.
Sourced in United States, Japan, United Kingdom, Austria, Germany, Czechia, Belgium, Denmark, Canada
SPSS version 22.0 is a statistical software package developed by IBM. It is designed to analyze and manipulate data for research and business purposes. The software provides a range of statistical analysis tools and techniques, including regression analysis, hypothesis testing, and data visualization.
Sourced in United States, Japan, Belgium, United Kingdom, Germany
SPSS software version 22.0 is a comprehensive statistical analysis tool designed to handle a wide range of data types and perform advanced analytical tasks. The software provides a user-friendly interface and a robust set of statistical procedures, enabling researchers, analysts, and professionals to effectively analyze and interpret data.
Sourced in United States
TreeAge Pro 2017 is a software application designed for decision analysis and cost-effectiveness analysis. It provides a platform for building and analyzing decision trees, Markov models, and other types of models used in healthcare and other industries.
Sourced in United States, Japan, Austria, Germany, United Kingdom, France, Cameroon, Denmark, Israel, Sweden, Belgium, Italy, China, New Zealand, India, Brazil, Canada
SAS software is a comprehensive analytical platform designed for data management, statistical analysis, and business intelligence. It provides a suite of tools and applications for collecting, processing, analyzing, and visualizing data from various sources. SAS software is widely used across industries for its robust data handling capabilities, advanced statistical modeling, and reporting functionalities.
Sourced in United States, Austria, United Kingdom, Cameroon, Belgium, Israel, Japan, Australia, France, Germany
SAS v9.4 is a software product developed by SAS Institute. It is a comprehensive data analysis and statistical software suite. The core function of SAS v9.4 is to provide users with tools for data management, analysis, and reporting.

More about "Cancer Survivorship"

Cancer survivorship encompasses the health and well-being of individuals from the time of initial cancer diagnosis through the remainder of their lives.
This includes the physical, psychological, and social aspects, as well as the effects of the cancer and its treatment.
Key areas of focus in cancer survivorship research include managing long-term and late effects, promoting wellness and prevention, and addressing disparities in survivorship outcomes.
Survivorship research aims to optimize care and improve quality of life for those living with and beyond cancer.
Synonyms and related terms include oncology survivorship, post-treatment cancer care, and life after cancer.
Abbreviations like QoL (quality of life) and HRQOL (health-related quality of life) are commonly used.
Subtopics in cancer survivorship research include symptom management, rehabilitation, mental health, financial/employment issues, and health promotion.
Statistcal analysis tools like SAS version 9.4, Stata V.16, SPSS version 22.0, and TreeAge Pro 2017 are often utilized to study survivorship outcomes and evaluate interventions.
Reserchers may also leverage SAS System for Windows, SPSS software version 22.0, and SAS softwae v9.4 to support their cancer survivorship studies.
By incorporating these insights, researchers can advance the field and enhance the lives of cancer survivors.